Vigilare Wealth Management Zymeworks Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$15.19 - $29.33 $154,938 - $299,166	-10,200 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$27.35 - $37.28 $278,970 - $380,256	10,200 New	10,200 $296,000
Q1 2021 Apr 29, 2021	SELL	$29.83 - $56.81 $139,455 - $265,586	-4,675 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$39.12 - $54.99 $11,540 - $16,222	-295 Reduced 5.94%	4,675 $221,000
Q3 2020 Oct 15, 2020	SELL	$29.21 - $46.58 $31,838 - $50,772	-1,090 Reduced 17.99%	4,970 $232,000
Q2 2020 Jul 20, 2020	BUY	$33.67 - $40.0 $204,040 - $242,400	6,060 New	6,060 $219,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $872M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.